Legend Biotech (LEGN) Capital Expenditures Growth (1y) (2020 - 2026)
Legend Biotech (LEGN) Capital Expenditures Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -22.99% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 9.68% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -37.81% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -34.23% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 22,433.30% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 142.64% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -73.62% |
| 10 | Legend Biotech | 3.95 Bn | 3.27 Bn | 251.50 Mn | -18.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -18.48% |
| Mar 31, 2026 | 275.00% |
| Sep 30, 2025 | -1,431.12% |
| Jun 30, 2025 | -4,583.39% |
| Mar 31, 2025 | 132.04% |
| Dec 31, 2024 | -27.89% |
| Sep 30, 2024 | -10.26% |
| Jun 30, 2024 | -72.20% |
| Mar 31, 2024 | -46.07% |
| Dec 31, 2023 | 271.18% |
| Sep 30, 2023 | 116.25% |
| Jun 30, 2023 | 108.81% |
| Mar 31, 2023 | -1,756.59% |
| Dec 31, 2022 | 50.41% |
| Sep 30, 2022 | -245.98% |
| Jun 30, 2022 | -648.02% |
| Mar 31, 2022 | 2,680.00% |
| Dec 31, 2021 | -60.73% |
| Sep 30, 2021 | 261,529.63% |
| Jun 30, 2021 | 103,483.22% |